365 – NK-Cell Immunotherapy Administered at the Time of HIV Rebound Is Associated With Viral Control
Background Although ART has improved survival rates and quality of life for people living with HIV-1 (PLWH), these drugs require lifelong adherence and are not a cure. Reservoirs of HIV persist in B cell follicles of lymphatic tissues even during ART treatment. This reservoir is driven by a paucity of HIV-specific cytotoxic cells in these…